| Ms Brenda Waters, NP | |
|
915 Clingan Ridge Dr Nw, Cleveland, TN 37312-3729 | |
| (423) 339-3340 | |
| (423) 339-9927 |
| Full Name | Ms Brenda Waters |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 915 Clingan Ridge Dr Nw, Cleveland, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134193618 | NPI | - | NPPES |
| 1134193618 | Medicaid | TN |
| Entity Name | Nv Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210903001263 |
News Archive
Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as "chemo brain."
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed the first close on its Series B equity financing of up to $25 million led by SV Life Sciences (SVLS) along with existing investor, Kleiner Perkins Caufield & Byers (KPCB).
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center researchers more than $7.5 million in research grants to improve diagnostic and therapeutic services and research relating to cancers of the brain, breast, throat, and bone, as well as to improve scientific understanding of cancer biology.
Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Brenda Waters, NP 1021 Executive Dr, Suite 102, Hixson, TN 37343-7918 Ph: (423) 870-0046 | Ms Brenda Waters, NP 915 Clingan Ridge Dr Nw, Cleveland, TN 37312-3729 Ph: (423) 339-3340 |
News Archive
Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as "chemo brain."
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed the first close on its Series B equity financing of up to $25 million led by SV Life Sciences (SVLS) along with existing investor, Kleiner Perkins Caufield & Byers (KPCB).
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center researchers more than $7.5 million in research grants to improve diagnostic and therapeutic services and research relating to cancers of the brain, breast, throat, and bone, as well as to improve scientific understanding of cancer biology.
Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
› Verified 2 days ago
Janet Leigh Zarzour, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3530 Keith St Nw, Cleveland, TN 37312 Phone: 615-673-6737 Fax: 800-474-4039 | |
Miss Margie Amanda Cook, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2253 Chambliss Ave Nw, Suite 202, Cleveland, TN 37311 Phone: 423-472-3332 Fax: 423-472-3830 | |
Marissa Lyn Withrow, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2424 N Ocoee St, Cleveland, TN 37311 Phone: 866-389-2727 Fax: 401-216-3854 | |
Robert Breck Lang, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2020 Westland Dr Sw, Cleveland, TN 37311 Phone: 423-478-1970 | |
Lindsey C Baxter, AGACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1482 Old Charleston Rd Ne, Cleveland, TN 37312 Phone: 423-544-9596 | |
Mary Michelle Youngblood, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2085 Brentwood Trl Sw, Cleveland, TN 37311 Phone: 423-284-9390 | |
Kellye Fryar, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 463 1st St Nw, Cleveland, TN 37311 Phone: 423-790-7662 Fax: 423-790-7664 |